CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Morgan Stanley Adjusts Price Target on Disc Medicine to $90 From $85, Keeps Overweight Rating

Positive
AI Analysis

Summary

Morgan Stanley raised its price target on Disc Medicine to $90 from $85 while maintaining an Overweight rating.

Importance:2/10
Sentiment:
0.30
analyst_ratingprice_targetequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 17, 2026 9:48 AM

Read Original